EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

HADH suppresses clear cell renal cell carcinoma progression through reduced NRF2-dependent glutathione synthesis

Changbin Chu, Shangjing Liu, Zhiting He, Mingjun Wu, Jing Xia, Hongxiang Zeng, Wenhua Xie, Rui Cheng, Xueya Zhao, Xi Li

Translational Oncology · 2024-11 · 49 · 102112

DOI: 10.1016/j.tranon.2024.102112 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Translational Oncology, 2024-11. Verfasst von Changbin Chu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Life Sciences, Chongqing Medical University, Chongqing, 400016, China; Department of Urology, Chongqing Red Cross Hospital (People's Hos…. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Chongqing Municipal Education Commission, National Natural Science Foundation of China, National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Clear cell renal cell carcinoma (ccRCC) is a serious threat to human life. It is very important to clarify the pathogenesis of ccRCC. In this study we evaluated the clinical value of HADH and explored its role and mechanism in the malignant progression of ccRCC. METHODS: HADH expression and its relationship with prognosis were analyzed using bioinformatics database. RT-PCR, Western blot and immunohistochemistry were used to examine the expression of HADH in ccRCC tissues and tissue microarrays. To examine the cell proliferation, apoptosis, migration and invasion ability, ccRCC cells with HADH overexpressed were constructed. Xenograft experiments were performed to determine the role of HADH. Non-target metabolomics was applied to explore the potential metabolic pathway by which HADH inhibited ccRCC progression. Plasmid pcDNA3.1-NRF2 was used to confirm whether HADH inhibited the process of ccRCC cells through NRF2-related glutathione (GSH) synthesis. RESULTS: Bioinformatics database analysis showed that HADH expression was significantly decreased in ccRCC tissues, and its low expression predicted a poor prognosis. Both ccRCC tissues and tissue microarrays exhibited a significantly decreased HADH level compared with adjacent normal renal tissues. HADH overexpression inhibited the malignant behaviors of ccRCC cells. Furthermore, HADH overexpression attenuated GSH synthesis and induced oxidative stress damage. Exogenously increased NRF2 effectively attenuated the inhibitive effect of HADH overexpression on ccRCC cells. CONCLUSION: Our data revealed that HADH suppressed the malignant behaviors of ccRCC cells by attenuating GSH synthesis through inhibition of NRF2 nuclear translocation, and HADH might be a novel therapeutic target for ccRCC treatment.

Schlagwörter

Stichwörter der Autor:innen

Clear cell renal cell carcinomaGlutathione synthesisHADHNRF2Non-target metabolomics

Autor:innen und Institutionen

  • Institute of Life Sciences, Chongqing Medical University, Chongqing, 400016, China; Department of Urology, Chongqing Red Cross Hospital (People's Hospital of Jiangbei District), Chongqing, 400020, China.
  • School of Basic Medicine, Chongqing Medical University, Chongqing, 400016, China.
  • Institute of Life Sciences, Chongqing Medical University, Chongqing, 400016, China.
  • Medical Center of Hematology, Xinqiao Hospital, Army Medical University, Chongqing, China.
  • Institute of Life Sciences, Chongqing Medical University, Chongqing, 400016, China. Electronic address: lixi@cqmu.edu.cn.

Förderung

  • Chongqing Municipal Education Commission
  • National Natural Science Foundation of China
  • National Key Research and Development Program of China
  • Natural Science Foundation of Chongqing Municipality
  • Chongqing Medical University

Zitieren

APA

Chu, C., Liu, S., He, Z., Wu, M., Xia, J., Zeng, H., Xie, W., Cheng, R., Zhao, X., & Li, X. (2024). HADH suppresses clear cell renal cell carcinoma progression through reduced NRF2-dependent glutathione synthesis. Translational Oncology, 49, 102112. https://doi.org/10.1016/j.tranon.2024.102112

Vancouver

Chu C, Liu S, He Z, Wu M, Xia J, Zeng H, et al. HADH suppresses clear cell renal cell carcinoma progression through reduced NRF2-dependent glutathione synthesis. Translational Oncology. 2024;49:102112. doi:10.1016/j.tranon.2024.102112

BibTeX
@article{Chu2024,
  author = {Chu, Changbin and Liu, Shangjing and He, Zhiting and Wu, Mingjun and Xia, Jing and Zeng, Hongxiang and Xie, Wenhua and Cheng, Rui and Zhao, Xueya and Li, Xi},
  title = {HADH suppresses clear cell renal cell carcinoma progression through reduced NRF2-dependent glutathione synthesis},
  journal = {Translational Oncology},
  year = {2024},
  volume = {49},
  pages = {102112},
  doi = {10.1016/j.tranon.2024.102112}
}
Kostenlos starten →